Source - RNS
RNS Number : 7811K
ABCAM Plc
26 September 2016
 

For immediate release

26 September 2016

ABCAM PLC

("Abcam")

Posting of Annual Report and Accounts

 

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces that its Annual Report and Accounts for the year ended 30 June 2016 has been posted to shareholders and is available at the Company's investor relations website, www.abcamplc.com.

 

 

For further information, please contact:

Abcam


Suzanne Smith, Company Secretary

Julia Wilson, Investor Relations

+ 44 (0) 1223 696 000



J.P.Morgan Cazenove - Nominated Adviser & Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Chris Cargill

 

FTI Consulting

Ben Atwell / Brett Pollard / Natalie Garland-Collins

 

 

+44 (0) 20 3727 1000



 

Notes to Editors

About Abcam plc

 

As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways.

 

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use Abcam's affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.

 

By actively listening to and collaborating with researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.

 

Abcam's twelve locations are in the world's leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the Company sells to more than 100 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).

 

To find out more, please visit www.abcam.com and www.abcamplc.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSAKADDABKKACB

Related Charts

Abcam (ABC)

-2.50p (-0.32%)
delayed 18:15PM